Summary

Blood Group Typing Market – Scope of Report
TMR’s report on the global blood group typing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global blood group typing market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood group typing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the blood group typing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood group typing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood group typing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood group typing market.

The report delves into the competitive landscape of the global blood group typing market. Key players operating in the global blood group typing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood group typing market profiled in this report.

Key Questions Answered in Global blood group typing Market Report
• What is the sales/revenue generated by blood group typing across all regions during the forecast period?
• What are the opportunities in the global blood group typing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Blood Group Typing Market – Research Objectives and Research Approach
The comprehensive report on the global blood group typing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood group typing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood group typing market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Blood Group Typing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Group Typing Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Blood Group Typing Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Instruments
6.3.1.1. Automated
6.3.1.2. Semi-automated
6.3.1.3. Manual
6.3.2. Consumables
6.3.2.1. Reagents
6.3.2.2. Test Kits
6.3.2.3. Antisera
6.3.2.4. Others
6.3.3. Services
6.4. Market Attractiveness, by Product
7. Global Blood Group Typing Market Analysis and Forecast, by Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technique, 2017–2031
7.3.1. PCR-based
7.3.2. Microarray-based
7.3.3. Assay-based
7.3.4. Massively Parallel
7.3.5. 7.4 Market Attractiveness, by Technique
8. Global Blood Group Typing Market Analysis and Forecast, by Test
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Test, 2017–2031
8.3.1. Antibody Screening
8.3.2. HLA Typing
8.3.3. ABO Matching Test
8.3.4. Cross Matching Test
8.3.5. Antigen Typing
8.4. Market Attractiveness, by Test
9. Global Blood Group Typing Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Clinical Laboratories
9.3.3. Blood Banks
9.3.4. Others
9.4. Market Attractiveness, by End-user
10. Global Blood Group Typing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Blood Group Typing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Instruments
11.2.1.1. Automated
11.2.1.2. Semi-automated
11.2.1.3. Manual
11.2.2. Consumables
11.2.2.1. Reagents
11.2.2.2. Test Kits
11.2.2.3. Antisera
11.2.2.4. Others
11.2.3. Services
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Technique, 2017–2031
11.4.1. PCR-based
11.4.2. Microarray-based
11.4.3. Assay-based
11.4.4. Massively Parallel
11.5. Market Attractiveness, by Technique
11.6. Market Value Forecast, by Test, 2017–2031
11.6.1. Antibody Screening
11.6.2. HLA Typing
11.6.3. ABO Matching Test
11.6.4. Cross Matching Test
11.6.5. Antigen Typing
11.7. Market Attractiveness, by Test
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals
11.8.2. Clinical Laboratories
11.8.3. Blood Banks
11.8.4. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product
11.11.2. By Technique
11.11.3. By Test
11.11.4. By End-user
11.11.5. By Country
12. Europe Blood Group Typing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Instruments
12.2.1.1. Automated
12.2.1.2. Semi-automated
12.2.1.3. Manual
12.2.2. Consumables
12.2.2.1. Reagents
12.2.2.2. Test Kits
12.2.2.3. Antisera
12.2.2.4. Others
12.2.3. Services
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technique, 2017–2031
12.4.1. PCR-based
12.4.2. Microarray-based
12.4.3. Assay-based
12.4.4. Massively Parallel
12.5. Market Attractiveness, by Technique
12.6. Market Value Forecast, by Test, 2017–2031
12.6.1. Antibody Screening
12.6.2. HLA Typing
12.6.3. ABO Matching Test
12.6.4. Cross Matching Test
12.6.5. Antigen Typing
12.7. Market Attractiveness, by Test
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals
12.8.2. Clinical Laboratories
12.8.3. Blood Banks
12.8.4. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product
12.11.2. By Technique
12.11.3. By Test
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Blood Group Typing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Instruments
13.2.1.1. Automated
13.2.1.2. Semi-automated
13.2.1.3. Manual
13.2.2. Consumables
13.2.2.1. Reagents
13.2.2.2. Test Kits
13.2.2.3. Antisera
13.2.2.4. Others
13.2.3. Services
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technique, 2017–2031
13.4.1. PCR-based
13.4.2. Microarray-based
13.4.3. Assay-based
13.4.4. Massively Parallel
13.5. Market Attractiveness, by Technique
13.6. Market Value Forecast, by Test, 2017–2031
13.6.1. Antibody Screening
13.6.2. HLA Typing
13.6.3. ABO Matching Test
13.6.4. Cross Matching Test
13.6.5. Antigen Typing
13.7. Market Attractiveness, by Test
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals
13.8.2. Clinical Laboratories
13.8.3. Blood Banks
13.8.4. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product
13.11.2. By Technique
13.11.3. By Test
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Blood Group Typing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Instruments
14.2.1.1. Automated
14.2.1.2. Semi-automated
14.2.1.3. Manual
14.2.2. Consumables
14.2.2.1. Reagents
14.2.2.2. Test Kits
14.2.2.3. Antisera
14.2.2.4. Others
14.2.3. Services
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technique, 2017–2031
14.4.1. PCR-based
14.4.2. Microarray-based
14.4.3. Assay-based
14.4.4. Massively Parallel
14.5. Market Attractiveness, by Technique
14.6. Market Value Forecast, by Test, 2017–2031
14.6.1. Antibody Screening
14.6.2. HLA Typing
14.6.3. ABO Matching Test
14.6.4. Cross Matching Test
14.6.5. Antigen Typing
14.7. Market Attractiveness, by Test
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals
14.8.2. Clinical Laboratories
14.8.3. Blood Banks
14.8.4. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product
14.11.2. By Technique
14.11.3. By Test
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Blood Group Typing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Instruments
15.2.1.1. Automated
15.2.1.2. Semi-automated
15.2.1.3. Manual
15.2.2. Consumables
15.2.2.1. Reagents
15.2.2.2. Test Kits
15.2.2.3. Antisera
15.2.2.4. Others
15.2.3. Services
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Technique, 2017–2031
15.4.1. PCR-based
15.4.2. Microarray-based
15.4.3. Assay-based
15.4.4. Massively Parallel
15.5. Market Attractiveness, by Technique
15.6. Market Value Forecast, by Test, 2017–2031
15.6.1. Antibody Screening
15.6.2. HLA Typing
15.6.3. ABO Matching Test
15.6.4. Cross Matching Test
15.6.5. Antigen Typing
15.7. Market Attractiveness, by Test
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals
15.8.2. Clinical Laboratories
15.8.3. Blood Banks
15.8.4. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product
15.11.2. By Technique
15.11.3. By Test
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Grifols, S.A.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Bio-Rad Laboratories, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Merck KGaA
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Ortho Clinical Diagnostics
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. AliveDx
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. ABG Health Care GmbH
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Immucor, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Danaher Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Agena Bioscience, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Rapid Labs Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Novacyt Group
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview